CUOG PHASE II RANDOMIZED STUDY OF CUSTIRSEN (OGX-011) COMBINATION THERAPY IN PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER (CRPC) WHO RELAPSED ON OR WITHIN SIX MONTHS OF 1ST-LINE DOCETAXEL THERAPY Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Saad, Fred
  • Hotte, Sebastien
  • North, Scott
  • Eigl, Bernard
  • Chi, Kim
  • Czaykowski, Piotr
  • Pollak, Michael
  • Wood, Lori
  • Winquist, Eric

publication date

  • April 2009